Latest Breaking News On - Curr alzheimer res - Page 1 : comparemela.com

PRESS RELEASE END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE .

Medesis pharmaJacques touchonNeuropharmacology laboratory of mcgill universityProfessor emeritus of the university montpellierProfessor emeritusClinical trialsNeuropharmacology laboratoryMcgill universityMicrodose lithiumPre plaque oxidative damageRat modelCurr alzheimer resMicrodose lithium formulationBlunts early amyloid post plaque neuropathologyLike transgenicTreatment option